GlycoMimetics Inc (STU:GKO)
€ 0.2905 -0.0145 (-4.75%) Market Cap: 19.25 Mil Enterprise Value: 5.78 Mil PE Ratio: 0 PB Ratio: 1.78 GF Score: 23/100

GlycoMimetics Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 08:00PM GMT
Release Date Price: €1.71 (-8.73%)
Roger Song
Jefferies - Analyst

Welcome, everyone. And our next presenting company is GlycoMimetics. And I welcome CEO, Harout Semerjian. How are you?

Harout Semerjian
GlycoMimetics, Inc. - President & CEO

I'm very good. Thank you.

Questions & Answers

Roger Song
Jefferies - Analyst

Awesome. Yeah. Maybe before we talk about your exciting program and the upcoming catalysts, just for the people who maybe already know GlycoMimetics, but maybe some of them are new to the story, what's your updated elevator pitch for investors?

Harout Semerjian
GlycoMimetics, Inc. - President & CEO

Thank you, Roger. GlycoMimetics is a clinical-stage company, actually a late-clinical stage company at this point, really focusing on debilitating diseases such as oncology, hematology, inflammatory diseases. We have a proprietary platform dealing with carbohydrates and glycobiology, which we believe is a very exciting area. And now more and more, we're starting to bring some of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot